Triazole Evolution of Candida parapsilosis Results in Cross-Resistance to Other Antifungal Drugs, Influences Stress Responses, and Alters Virulence in an Antifungal Drug-Dependent Manner

Trimmomatic: a flexible trimmer for Illumina sequence data

Bolger, A. M., Lohse, M., & Usadel, B. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btu170 · Cited by 65,548 · see citing works

Aligning sequence reads, clone sequences and assembly contigs with BWA-MEMPreprint

Li, H. (2013) · arXiv (Cornell University) · doi:10.48550/arxiv.1303.3997 · Cited by 9,540 · see citing works

Aligning sequence reads, clone sequences and assembly con*gs with BWA-MEMPreprint

Li, H. (2014) · arXiv (Cornell University) · doi:10.6084/m9.figshare.963153.v1 · Cited by 5,150 · see citing works

Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America

Pappas, P. G., Kauffman, C. A., Andes, D. R., Clancy, C. J., Marr, K. A., Ostrosky-Zeichner, L., Reboli, A. C., Schuster, M. G., Vazquez, J. A., Walsh, T. J., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/civ933 · Cited by 4,200 · see citing works

Haplotype-based variant detection from short-read sequencing

Garrison, E., & Marth, G. (2012) · arXiv · doi:10.48550/arxiv.1207.3907 · Cited by 3,700 · see citing works

Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America

Pappas, P. G., Kauffman, C. A., Andes, D., Benjamin, D. K., Calandra, T. F., Edwards, J. E., Filler, S. G., Fisher, J. F., Kullberg, B.-J., Zeichner, L. O., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/596757 · Cited by 3,191 · see citing works

Reference method for broth dilution antifungal susceptibility testing of yeasts : Approved standard

Rex, J. H., & Clinical (2008) · Clinical and Laboratory Standards Institute eBooks · Cited by 1,052 · see citing works

Candida parapsilosis , an Emerging Fungal Pathogen

Trofa, D. P., Gácser, A., & Nosanchuk, J. D. (2008) · Clinical Microbiology Reviews · doi:10.1128/cmr.00013-08 · Cited by 862 · see citing works

Twenty Years of the SENTRY Antifungal Surveillance Program: Results for Candida Species From 1997–2016

Pfaller, M. A., Diekema, D. J., Turnidge, J. D., Castanheira, M., & Jones, R. N. (2019) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofy358 · Cited by 825 · see citing works

Clinical Practice Guidelines for the Management of Candidiasis: 2009 Update by the Infectious Diseases Society of America

Parczewska, O. K., Posaconazol, przeciwgrzybicze, L., Anidulafungina, Micafungina, & wrażliwość, O. (2009) · Cited by 656 · see citing works

History of the development of azole derivatives

Maertens, J. A. (2004) · Clinical Microbiology and Infection · doi:10.1111/j.1470-9465.2004.00841.x · Cited by 477 · see citing works

Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: 10.5-Year Analysis of Susceptibilities of Noncandidal Yeast Species to Fluconazole and Voriconazole Determined by CLSI Standardized Disk Diffusion Testing

Pfaller, M. A., Diekema, D. J., Gibbs, D. L., Newell, V. A., Hu, B., Dzierzanowska, D., Климко, Н. Н., Letscher‐Bru, V., Lisalová, M., Muehlethaler, K., et al. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.01747-08 · Cited by 370 · see citing works

The Transcription Factor Mrr1p Controls Expression of the MDR1 Efflux Pump and Mediates Multidrug Resistance in Candida albicans

Morschhäuser, J., Barker, K. S., Liu, T. T., Blaß-Warmuth, J., Homayouni, R., & Rogers, P. D. (2007) · PLoS Pathogens · doi:10.1371/journal.ppat.0030164 · Cited by 355 · see citing works

Candida parapsilosis: from genes to the bedside

Tóth, R., Nosek, J., Mora-Montes, H. M., Gabaldon, T., Bliss, J. M., Nosanchuk, J. D., Turner, S. A., Butler, G., Vágvölgyi, C., & Gácser, A. (2019) · Clinical Microbiology Reviews · doi:10.1128/cmr.00111-18 · Cited by 327 · see citing works

Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2005: an 8.5-Year Analysis of Susceptibilities of Candida Species and Other Yeast Species to Fluconazole and Voriconazole Determined by CLSI Standardized Disk Diffusion Testing

Pfaller, M. A., Diekema, D. J., Gibbs, D. L., Newell, V. A., Meis, J. F. G. M., Gould, I. M., Fu, W., Colombo, A. L., & Rodríguez-Noriega, E. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.00409-07 · Cited by 287 · see citing works

Epidemiology, Risk Factors, and Prognosis of Candida parapsilosis Bloodstream Infections: Case-Control Population-Based Surveillance Study of Patients in Barcelona, Spain, from 2002 to 2003

Almirante, B., Rodríguez-Pardo, D., Cuenca‐Estrella, M., Almela, M., Sánchez, F., Ayats, J., Alonso-Tarrés, C., Rodrı́guez-Tudela, J. L., Pahissa, A., & the Barcelona Candidemia Project Study Group (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.44.5.1681-1685.2006 · Cited by 241 · see citing works

Candida albicans Antifungal Resistance and Tolerance in Bloodstream Infections: The Triad Yeast-Host-Antifungal

Costa-de-Oliveira, S., & Rodrigues, A. G. (2020) · Microorganisms · doi:10.3390/microorganisms8020154 · Cited by 229 · see citing works

Emergence of Fluconazole Resistance in a Candida parapsilosis Strain That Caused Infections in a Neonatal Intensive Care Unit

Sarvikivi, E., Lyytikäinen, O., Soll, D. R., Pujol, C., Pfaller, M. A., Richardson, M. D., Koukila-Kähkölä, P., Luukkainen, P., & Saxén, H. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.6.2729-2735.2005 · Cited by 177 · see citing works

Prospective Multicenter Study of the Epidemiology, Molecular Identification, and Antifungal Susceptibility of Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis Isolated from Patients with Candidemia

Cantón, E., Pemán, J., Quindós, G., Eraso, E., Miranda-Zapico, I., Álvarez, M., Merino, P., Campos-Herrero, M. I., Marco, F., de la Pedrosa, E. G. G., et al. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00466-11 · Cited by 157 · see citing works

Phenotype switching affects biofilm formation by Candida parapsilosis

Laffey, S. F., & Butler, G. (2005) · Microbiology · doi:10.1099/mic.0.27739-0 · Cited by 132 · see citing works

Responding to the Emergence of Antifungal Drug Resistance: Perspectives from the Bench and the Bedside

Beardsley, J., Halliday, C. L., Chen, S. C. ‐., & Sorrell, T. C. (2018) · Future Microbiology · doi:10.2217/fmb-2018-0059 · Cited by 126 · see citing works

Update from a 12-Year Nationwide Fungemia Surveillance: Increasing Intrinsic and Acquired Resistance Causes Concern

Astvad, K. M. T., Johansen, H. K., Røder, B. L., Rosenvinge, F. S., Knudsen, J. D., Lemming, L., Schønheyder, H. C., Hare, R. K., Kristensen, L., Nielsen, L., et al. (2018) · Journal of Clinical Microbiology · doi:10.1128/jcm.01564-17 · Cited by 125 · see citing works

Initial use of echinocandins does not negatively influence outcome in Candida parapsilosis bloodstream infection: A propensity score analysis

Fernández-Ruiz, M., Aguado, J. M., Almirante, B., Lora-Pablos, D., Padilla, B., Puig-Asensio, M., Montejo, M., García-Rodríguez, J., Pemán, J., Ruiz Pérez de Pipaón, M., et al. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu158 · Cited by 122 · see citing works

Candida parapsilosis Resistance to Fluconazole: Molecular Mechanisms and <i>In Vivo</i> Impact in Infected Galleria mellonella Larvae

Souza, A. C. R., Fuchs, B. B., Pinhati, H. M. S., Siqueira, R. A., Hagen, F., Meis, J. F., Mylonakis, E., & Colombo, A. L. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01177-15 · Cited by 121 · see citing works

Amino acid substitutions in the Candida albicans sterol  5,6-desaturase (Erg3p) confer azole resistance: characterization of two novel mutants with impaired virulence

Morio, F., Pagniez, F., Lacroix, C., Miegeville, M., & Le Pape, P. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks186 · Cited by 120 · see citing works

Contribution of CgPDR1-Regulated Genes in Enhanced Virulence of Azole-Resistant Candida glabrata

Ferrari, S., Sanguinetti, M., Torelli, R., Posteraro, B., & Sanglard, D. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017589 · Cited by 110 · see citing works

Candidaemia associated with decreased in vitro fluconazole susceptibility: is Candida speciation predictive of the susceptibility pattern?

Oxman, D., Chow, J. K. L., Frendl, G., Hadley, S., Hershkovitz, S., Ireland, P., McDermott, L. A., Tsai, K., Marty, F. M., Kontoyiannis, D. P., et al. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq136 · Cited by 104 · see citing works

Changes in susceptibility to posaconazole in clinical isolates of Candida albicans

Li, X. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh027 · Cited by 96 · see citing works

Emergence of non-Candida albicans species: Epidemiology, phylogeny and fluconazole susceptibility profile

Sadeghi, G., Ebrahimi-Rad, M., Mousavi, S. F., Shams-Ghahfarokhi, M., & Razzaghi-Abyaneh, M. (2018) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2017.12.008 · Cited by 96 · see citing works

Multidrug transporters and alterations in sterol biosynthesis contribute to azole antifungal resistance in Candida parapsilosis

Berkow, E. L., Manigaba, K., Parker, J. E., Barker, K. S., Kelly, S. L., & Rogers, P. D. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01358-15 · Cited by 95 · see citing works

Increasing candidaemia incidence from 2004 to 2015 with a shift in epidemiology in patients preexposed to antifungals

Goemaere, B., Becker, P., Wijngaerden, E. V., Maertens, J. A., Spriet, I., Hendrickx, M., & Lagrou, K. (2017) · Mycoses · doi:10.1111/myc.12714 · Cited by 91 · see citing works

Transcriptional profiling of azole-resistant Candida parapsilosis strains

Silva, A. P., Miranda, I. M., Guida, A., Synnott, J., Rocha, R., Silva, R., Amorim, A., Pina-Vaz, C., Butler, G., & Rodrigues, A. G. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01127-10 · Cited by 86 · see citing works

Changes of virulence factors accompanying the phenomenon of induced fluconazole resistance in Candida albicans

Forgács, K., Gyüre, L., & Lenkey, B. (2000) · Mycoses · doi:10.1046/j.1439-0507.2000.00587.x · Cited by 69 · see citing works

ERG3 and ERG11 genes are critical for the pathogenesis of Candida albicans during the oral mucosal infection

Zhou, Y., Liao, M., Zhu, C., Hu, Y. H., Tong, T., Peng, X., Li, M., Feng, M., Cheng, L., Ren, B., et al. (2018) · International Journal of Oral Science · doi:10.1038/s41368-018-0013-2 · Cited by 66 · see citing works

Voriconazole in the management of nosocomial invasive fungal infections

Pemán, J., Salavert, M., Cant�n, E., Jarque, I., Rom, E., Zaragoza, R., Viudes, �., & Gobernado, M. (2006) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.2006.2.2.129 · Cited by 61 · see citing works

Determination of ergosterol in Fusarium-infected wheat by liquid chromatography–atmospheric pressure photoionization mass spectrometry

Varga, M., Bartók, T., & Mesterházy, Á. (2006) · Journal of Chromatography A · doi:10.1016/j.chroma.2005.11.051 · Cited by 53 · see citing works

Loss of C-5 Sterol Desaturase Activity Results in Increased Resistance to Azole and Echinocandin Antifungals in a Clinical Isolate of Candida parapsilosis

Rybak, J. M., Dickens, C. M., Parker, J. E., Caudle, K. E., Manigaba, K., Whaley, S. G., Nishimoto, A. T., Luna-Tapia, A., Roy, S., Zhang, Q., et al. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00651-17 · Cited by 53 · see citing works

Echinocandin-Induced Microevolution of Candida parapsilosis Influences Virulence and Abiotic Stress Tolerance

Papp, C., Kocsis, K., Tóth, R., Bodai, L., Willis, J. R., Księżopolska, E., Lozoya‐Pérez, N. E., Vágvölgyi, C., Montes, H. M. M., Gabaldón, T., et al. (2018) · mSphere · doi:10.1128/msphere.00547-18 · Cited by 51 · see citing works

Fluconazole and Voriconazole Resistance in Candida parapsilosis Is Conferred by Gain-of-Function Mutations in MRR1 Transcription Factor Gene

Branco, J., Silva, A. P., Silva, R. M., Silva-Dias, A., Pina‐Vaz, C., Butler, G., Rodrigues, A. G., & Miranda, I. M. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00842-15 · Cited by 49 · see citing works

<i>In Vitro</i> Antifungal Susceptibility Testing of Candida Isolates with the EUCAST Methodology, a New Method for ECOFF Determination

Meletiadis, J., Curfs-Breuker, I., Meis, J. F., & Mouton, J. W. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02372-16 · Cited by 38 · see citing works

Loss of Upc2p-Inducible <i>ERG3</i> Transcription Is Sufficient To Confer Niche-Specific Azole Resistance without Compromising Candida albicans Pathogenicity

Luna-Tapia, A., Willems, H. M. E., Parker, J. E., Tournu, H., Barker, K. S., Nishimoto, A. T., Rogers, P. D., Kelly, S. L., Peters, B. M., & Palmer, G. E. (2018) · mBio · doi:10.1128/mbio.00225-18 · Cited by 29 · see citing works

Regulation of ERG3, ERG6, and ERG11 Genes in Antifungal-Resistant isolates of Candida parapsilosis

Lotfali, E., Ghajari, A., Kordbacheh, P., Zaini, F., Mirhendi, H., Mohammadi, R., Noorbakhsh, F., & Rezaie, S. (2017) · Iranian Biomedical Journal · doi:10.18869/acadpub.ibj.21.4.275 · Cited by 22 · see citing works

Using the Candida Genome Database

Skrzypek, M. S., Binkley, J., & Sherlock, G. J. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-7737-6_3 · Cited by 18 · see citing works

Exploring the In Vitro Resistance of Candida parapsilosis to Echinocandins

Chassot, F., Venturini, T. P., Piasentin, F. B., Rossato, L. L., Fiorini, A., Svidzinski, T. I. E., & Alves, S. H. (2016) · Mycopathologia · doi:10.1007/s11046-016-0028-1 · Cited by 17 · see citing works

Therapeutic efficacy of voriconazole against a fluconazole-resistant Candida albicans isolate in a vaginal model

González, G. M., Portillo-Castillo, O. J., Uscanga, G. I., Andrade, S. E., Robledo, M., Rodriguez-Vivian, C., & Elizondo-Zertuche, M. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp228 · Cited by 16 · see citing works

Flow cytometric, phase-resolved fluorescence measurement of propidium iodide uptake in macrophages containing phagocytized fluorescent microspheres

Steinkamp, J. A., Valdez, Y. E., & Lehnert, B. E. (2000) · Cytometry · doi:10.1002/(sici)1097-0320(20000101)39:1 · Cited by 14 · see citing works

Anidulafungin versus fluconazole: clinical focus on IDSA and ESCMID guidelines.

Rosa, F. G. D., Motta, I., Corcione, S., Cattel, F., Perri, G. D., & D’Avolio, A. (2014) · PubMed · Cited by 4 · see citing works

Molecular mechanisms governing antifungal drug resistance

Lee, Y., Robbins, N., & Cowen, L. E. (2023) · npj Antimicrobials and Resistance · doi:10.1038/s44259-023-00007-2 · Cited by 304 · see citing works

Candida parapsilosis Virulence and Antifungal Resistance Mechanisms: A Comprehensive Review of Key Determinants

Branco, J., Miranda, I. M., & Rodrigues, A. G. (2023) · Journal of Fungi · doi:10.3390/jof9010080 · Cited by 133 · see citing works

Narrow mutational signatures drive acquisition of multidrug resistance in the fungal pathogen Candida glabrata

Ksiezopolska, E., Schikora-Tamarit, M. À., Beyer, R., Nunez-Rodriguez, J. C., Schüller, C., & Gabaldón, T. (2021) · Current Biology · doi:10.1016/j.cub.2021.09.084 · Cited by 107 · see citing works

Resistance to Antifungal Drugs

Ben‐Ami, R., & Kontoyiannis, D. P. (2021) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2021.03.003 · Cited by 101 · see citing works

Candida parapsilosis complex in the clinical setting

Govrins, M. A., & Lass‐Flörl, C. (2023) · Nature Reviews Microbiology · doi:10.1038/s41579-023-00961-8 · Cited by 77 · see citing works

The effect of antifungal resistance development on the virulence of Candida species

Bohner, F., Papp, C., & Gácser, A. (2022) · FEMS Yeast Research · doi:10.1093/femsyr/foac019 · Cited by 62 · see citing works

Antifungal Development and the Urgency of Minimizing the Impact of Fungal Diseases on Public Health

de Oliveira, H. C., Bezerra, B. T., & Rodrigues, M. L. (2022) · ACS Bio & Med Chem Au · doi:10.1021/acsbiomedchemau.2c00055 · Cited by 41 · see citing works

How urgent is the need for new antifungals?

Stewart, A. G., & Paterson, D. L. (2021) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2021.1935868 · Cited by 36 · see citing works

Collateral sensitivity counteracts the evolution of antifungal drug resistance in Candida auris

Carolus, H., Sofras, D., Boccarella, G., Jacobs, S., Biriukov, V. V., Goossens, L., Chen, A., Vantyghem, I., Verbeeck, T., Pierson, S., et al. (2024) · Nature Microbiology · doi:10.1038/s41564-024-01811-w · Cited by 27 · see citing works

Antifungal drug resistance: Deciphering the mechanisms governing multidrug resistance in the fungal pathogen Candida glabrata

Robbins, N., & Cowen, L. E. (2021) · Current Biology · doi:10.1016/j.cub.2021.09.071 · Cited by 24 · see citing works

Alternative ergosterol biosynthetic pathways confer antifungal drug resistance in the human pathogens within the Mucor species complex

Navarro-Mendoza, M. I., Arques, C. P., Parker, J. E., Xu, Z., Kelly, S. L., & Heitman, J. (2024) · mBio · doi:10.1128/mbio.01661-24 · Cited by 20 · see citing works

High MICs for antifungal agents in yeasts from an anthropized lagoon in South America

Pagani, D. M., Heidrich, D., Tormente, F. V., Milani, G., Jank, L., They, N. H., Valente, P., & Scroferneker, M. L. (2022) · Microbiological Research · doi:10.1016/j.micres.2022.127083 · Cited by 15 · see citing works

Candida Isolates From Blood and Other Normally Sterile Foci From ICU Patients: Determination of Epidemiology, Antifungal Susceptibility Profile and Evaluation of Associated Risk Factors

Wang, B., He, X., Lü, F., Li, Y., Wang, Y., Zhang, M., Huang, Y., & Xia, J. (2021) · Frontiers in Public Health · doi:10.3389/fpubh.2021.779590 · Cited by 15 · see citing works

Unlocking the potential of experimental evolution to study drug resistance in pathogenic fungi

Jacobs, S., Boccarella, G., van den Berg, P., Dijck, P. V., & Carolus, H. (2024) · npj Antimicrobials and Resistance · doi:10.1038/s44259-024-00064-1 · Cited by 13 · see citing works

Genetic Manipulation as a Tool to Unravel Candida parapsilosis Species Complex Virulence and Drug Resistance: State of the Art

Zoppo, M., Poma, N. V., Luca, M. D., Bottai, D., & Tavanti, A. (2021) · Journal of Fungi · doi:10.3390/jof7060459 · Cited by 14 · see citing works

Microbial and microscopic investigations to assess the susceptibility of Candida parapsilosis and Prototheca ciferrii to phyco-synthesized titanium dioxide nanoparticles and antimicrobial drugs

Hifney, A. F., Soliman, Z. S. M., Ali, E. F., & Hussein, N. A. (2022) · South African Journal of Botany · doi:10.1016/j.sajb.2022.11.004 · Cited by 13 · see citing works

Emerging antifungal resistance in Candida parapsilosis: the end of the innocence

Guinea, J., Escribano, P., Cadeau, M., Lombardi, L., & Morio, F. (2025) · npj Antimicrobials and Resistance · doi:10.1038/s44259-025-00173-5 · Cited by 13 · see citing works

The hidden threat: Unveiling the rise of antifungal drug resistance

Chaudhary, R., & Thakur, Z. (2025) · Microbial Pathogenesis · doi:10.1016/j.micpath.2025.108068 · Cited by 12 · see citing works

Deciphering of Candida parapsilosis induced immune response in Drosophila melanogaster

Csonka, K., Tasi, Z., Vedelek, V., Vágvölgyi, C., Sinka, R., & Gácser, A. (2021) · Virulence · doi:10.1080/21505594.2021.1980989 · Cited by 9 · see citing works

Epidemiological Attributes of Candida Species in Tropical Regions

Bohner, F., Gácser, A., & Tóth, R. (2021) · Current Tropical Medicine Reports · doi:10.1007/s40475-021-00226-5 · Cited by 9 · see citing works

Characterization and functional analysis of zinc trafficking in the human fungal pathogen Candida parapsilosis

Takács, T., Németh, M. T., Bohner, F., Vágvölgyi, C., Jankovics, F., Wilson, D., & Gácser, A. (2022) · Open Biology · doi:10.1098/rsob.220077 · Cited by 7 · see citing works

Experimental evolution of drug resistance in human fungal pathogens

Gerstein, A. C., & Sethi, P. (2022) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2022.101965 · Cited by 9 · see citing works

Acquired Triazole Resistance Alters Pathogenicity-Associated Features in Candida auris in an Isolate-Dependent Manner

Bohner, F., Papp, C., Takács, T., Varga, M., Szekeres, A., Nosanchuk, J. D., Vágvölgyi, C., Tóth, R., & Gácser, A. (2023) · Journal of Fungi · doi:10.3390/jof9121148 · Cited by 7 · see citing works

Nanoceria Anti-inflammatory and Antimicrobial Nanodrug: Cellular and Molecular Mechanism of Action

Gomes-da-Silva, N. C., Corrêa, L. B., González, M. M., França, Á. R. S., Alencar, L. M. R., Rosas, E. C., Ricci‐Júnior, E., Aguiar, T. K. B., Souza, P. F. N., & Santos‐Oliveira, R. (2024) · Current Medicinal Chemistry · doi:10.2174/0109298673285605231229112525 · Cited by 7 · see citing works

Experimental Evolution of Multidrug Resistance in Neurospora crassa under Antifungal Azole Stress

Zhou, M., Hu, C., Yin, Y., Wang, J., Ye, S., Yu, Y., Sun, X., & Li, S. (2022) · Journal of Fungi · doi:10.3390/jof8020198 · Cited by 6 · see citing works

Epistasis at the cell surface: what is the role of Erg3 loss-of-function in acquired echinocandin resistance?

Carolus, H., Díaz-García, J., Biriukov, V. V., Jacobs, S., Sofras, D., Pageau, A., Romero, C. L., Vinken, L., Escribano, P., Guinea, J., et al. (2025) · mBio · doi:10.1128/mbio.01419-25 · Cited by 5 · see citing works

Molecular Targeting and Novel Therapeutic Approaches against Fungal Infections

Kumar, A., Bansal, P., Katiyar, D., Prakash, G. K. S., & Rao, N. G. R. (2023) · Current Molecular Medicine · doi:10.2174/1566524023666230302123310 · Cited by 5 · see citing works

Constraint on boric acid resistance and tolerance evolvability in Candida albicans

Syvolos, Y., Salama, O. E., & Gerstein, A. C. (2024) · Canadian Journal of Microbiology · doi:10.1139/cjm-2023-0225 · Cited by 5 · see citing works

The Neosartorya (Aspergillus) fischeri antifungal protein NFAP2 has low potential to trigger resistance development in Candida albicans in vitro

Bende, G., Zsindely, N., Laczi, K., Kristóffy, Z., Papp, C., Farkas, A., Tóth, L., Sáringer, S., Bodai, L., Rákhely, G., et al. (2024) · Microbiology Spectrum · doi:10.1128/spectrum.01273-24 · Cited by 5 · see citing works

The IV International Symposium on Fungal Stress and the XIII International Fungal Biology Conference

Alder-Rangel, A., Bailão, A. M., Herrera‐Estrella, A., Rangel, A. E. A., Gácser, A., Gasch, A. P., de Campos, C. B. L., Peters, C., Camelim, F., Verde, F., et al. (2023) · Fungal Biology · doi:10.1016/j.funbio.2023.04.006 · Cited by 4 · see citing works

A prospective observational study on species differentiation and antifungal susceptibility pattern in patients with genital candidiasis

Sivagamasundari, S., Mahadevan, K., Rai, R., & Sriramajayam, L. (2024) · Indian Journal of Sexually Transmitted Diseases and AIDS · doi:10.4103/ijstd.ijstd_58_23 · Cited by 1 · see citing works

Uncovering actionable trade-offs of antifungal resistance in a yeast pathogen

Nunez‐Rodriguez, J. C., Schikora-Tamarit, M. À., & Gabaldón, T. (2026) · Molecular Systems Biology · doi:10.1038/s44320-025-00185-3 · Cited by 1 · see citing works

Incidence of azole resistance among clinical isolates of Candida parapsilosis: Results from the French nationwide multicenter prospective study “ReCap” 2022-2024

Fekkar, A., Blaize, M., Cassaing, S., Sendid, B., Pasquier, G., Imbert, S., Hennequin, C., Botterel, F., Morio, F., Ménotti, J., et al. (2026) · New Microbes and New Infections · doi:10.1016/j.nmni.2026.101738 · Cited by 1 · see citing works

In vitro induction of resistance to fluconazole and caspofungin in Candida parapsilosis complex species: Implications for virulence and cross-resistance to other antifungals

da Silva, B. V., de Oliveira, D. B. C., Felix, I. T. J., de Oliveira, R. T., Bezerra, R. D. O., Nascentes, G. A. N., & Andrade, A. A. (2025) · Microbial Pathogenesis · doi:10.1016/j.micpath.2025.108117 · Cited by 1 · see citing works

Investigation of Clinically Relevant Fluconazole Resistance Mechanisms in the Fungal Pathogen Candida parapsilosis

Doorley, L. A. (2023) · doi:10.21007/etd.cghs.2023.0620 · Cited by 1 · see citing works

Cyclical transcription factor AP2XII-9 is a key activator for asexual division and apicoplast inheritance in Toxoplasma gondii tachyzoitePreprint

Shi, Y., Li, X., Xue, Y., Hu, D., & Song, X. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.05.01.592006 · Cited by 1 · see citing works

The Emergence of Azole Resistance in Candida parapsilosis Isolates Causing Systemic Candidosis

Altıntaş, S. N., Aydoğan, C. N., & Aygar, İ. S. (2021) · Journal of Molecular Virology and Immunology · doi:10.46683/jmvi.2021.29

Susceptibilidad in vitro a antifúngicos de especies de Candida

Lee, D. C. M., Jaikel-Víquez, D., & Gross, N. (2023) · Acta Médica Costarricense · doi:10.51481/amc.v65i2.1263

Microbial metabolite p -cresol associates with constipation in adults with high-functioning autism spectrum disorder and induces constipation-like symptoms in micePreprint

Kraïmi, N., Fabregat‐Safont, D., Canaguier, J., Mallaret, G., Barbosa, S., Brouillet, J. Z., Lejuste, F., Gaman, A., Richard, J., Derbel, C. S., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2025.12.31.697262

Potential Antifungal Activity of Retinoids Against Non-albicans Candida Species

Cosio, T., Pistoia, E. S., Pica, F., Orlandi, A., Campione, E., & Gaziano, R. (2026) · Microorganisms · doi:10.3390/microorganisms14040759

Agricultural azole fungicides induce cross-resistance to medical antifungals in Candida tropicalis : a One Health perspective on antifungal resistance

Li, S., Hu, T., Li, C., Tan, T., Chu, H., & Huang, G. (2026) · Mycology&#58 An International Journal on Fungal Biology · doi:10.1080/21501203.2026.2657142

Advances in Azole Antifungal Agents: From Structural Foundations to Resistance Challenges

Yin, Y., Lu, W., Zhao, M., & Zhao, Y. (2026) · Journal of Fungi · doi:10.3390/jof12100728

DOI:10.1111/j.1567-1364.2009.00508.x

Teresa, A., Silva, P., Costa-de-oliveira, S., Silva-dias, A., Ana, C., & Silva, T. P. (2009)

Development of fluconazole resistance in a series of Candida parapsilosis isolates from a persistent candidemia patient with prolonged antifungal therapy

Zhang, L., Xiao, M., Watts, M. R., Wang, H., Fan, X., Kong, F., & Xu, Y.-C. (2015) · BMC Infectious Diseases · doi:10.1186/s12879-015-1086-6 · Cited by 62 · see citing works

Dynamics ofin vitro acquisition of resistance byCandida parapsilosisto different azoles

Silva, A. P., Costa‐de‐Oliveira, S., Silva-Dias, A., Pina‐Vaz, C., & Rodrigues, A. G. (2009) · FEMS Yeast Research · doi:10.1111/j.1567-1364.2009.00508.x · Cited by 32 · see citing works

Clinical azole cross-resistance in Candida parapsilosis is related to a novel MRR1 gain-of-function mutation

Branco, J., Ryan, A. P., Silva, A. P., Butler, G., Miranda, I. M., & Rodrigues, A. G. (2022) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2022.08.014 · Cited by 25 · see citing works

The Emergence of Azole Resistance in Candida parapsilosis Isolates Causing Systemic Candidosis

Altıntaş, S. N., Aydoğan, C. N., & Aygar, İ. S. (2021) · Journal of Molecular Virology and Immunology · doi:10.46683/jmvi.2021.29